Skip to main content
. 2014 Aug 15;2014(8):CD005355. doi: 10.1002/14651858.CD005355.pub5

Summary of findings 6. Gelatin‐thrombin matrix compared to placebo or no treatment to reduce blood loss during myomectomy for fibroids.

Gelatin‐thrombin matrix compared to placebo or no treatment to reduce blood loss during myomectomy for fibroids
Patient or population: Women with fibroids
 Settings: University teaching hospital in Spain
 Intervention: Gelatin‐thrombin matrix
 Comparison: Placebo or no treatment
Outcomes Illustrative comparative risks (95% CI) Relative effect
 (95% CI) No of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Placebo Gelatin‐thrombin matrix
Blood loss (ml) 
 Estimated blood loss during myomectomy The mean blood loss in placebo groups was
 625 ml The mean blood loss in intervention groups was
 545 ml lower 
 (593.26 to 496.74 lower) MD ‐545.00 (‐593.26 to ‐496.74) 50
 (1 study) ⊕⊕⊝⊝
 low1 We rated down the quality of evidence (by 2) because the data were derived from one small study, and it is unclear if outcome assessors were blind
Need for blood transfusion 
 Participants who received blood transfusion 400 per 1000 4 per 1000 
 (0 to 40) OR 0.01 
 (0 to 0.1) 50
 (1 study) ⊕⊕⊝⊝
 low1 We rated down the quality of evidence (by 2) because the data were derived from one small study, it is unclear if outcome assessors were blind, and the effect estimate was imprecise
Duration of surgery (min) 
 Operative time The mean duration of surgery in placebo group was
 60 min The mean duration of surgery in intervention group was
 5.00 min higher 
 (1.29 to 8.71 higher) MD 5.00
(1.29 to 8.71)
50
 (1 study) ⊕⊕⊝⊝
 low1 We rated down the quality of evidence (by 2) because the data were derived from one small study, it is unclear if outcome assessors were blind, and the effect estimate was imprecise
CI: Confidence interval;MD: Mean difference; OR: Odds ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1Allocation concealment not reported.